Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
14.10
-0.23 (-1.61%)
Apr 23, 2026, 1:22 PM EDT - Market open
Viridian Therapeutics Analyst Ratings
Total Analysts
14
Consensus Rating
Strong Buy
Price Target
$35.46
Upside
+151.49%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $36 → $33 | Strong Buy | Maintains | $36 → $33 | +134.04% | Apr 21, 2026 |
| Wedbush | Wedbush | Buy Maintains $37 → $31 | Buy | Maintains | $37 → $31 | +119.86% | Apr 8, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $36 → $31 | Strong Buy | Maintains | $36 → $31 | +119.86% | Apr 7, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $42 → $30 | Buy | Maintains | $42 → $30 | +112.77% | Apr 7, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $45 → $32 | Buy | Maintains | $45 → $32 | +126.95% | Apr 2, 2026 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $41 → $36 | Strong Buy | Maintains | $41 → $36 | +155.32% | Mar 31, 2026 |
| Wedbush | Wedbush | Buy Maintains $44 → $37 | Buy | Maintains | $44 → $37 | +162.41% | Mar 31, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $29 → $20 | Hold | Maintains | $29 → $20 | +41.84% | Mar 31, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $34 → $22 | Strong Buy | Maintains | $34 → $22 | +56.03% | Mar 31, 2026 |
| Needham | Needham | Strong Buy Maintains $42 → $32 | Strong Buy | Maintains | $42 → $32 | +126.95% | Mar 30, 2026 |
| Wedbush | Wedbush | Buy Reiterates $44 | Buy | Reiterates | $44 | +212.06% | Mar 11, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $45 → $42 | Buy | Maintains | $45 → $42 | +197.87% | Feb 27, 2026 |
| Needham | Needham | Strong Buy Reiterates $42 | Strong Buy | Reiterates | $42 | +197.87% | Feb 4, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $26 → $29 | Hold | Maintains | $26 → $29 | +105.67% | Feb 3, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $41 → $40 | Strong Buy | Maintains | $41 → $40 | +183.69% | Jan 8, 2026 |
| UBS | UBS | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +254.61% | Jan 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.